Previous studies found that MeCP2, as a new oncogene, was amplified in cancer cell lines and played a role in tumor cell proliferation, cell cycle, apoptosis, and invasion in several cancer types, such as osteosarcoma and gastric cancer6–8. This evidence concerns the gene MECP2 and cancer.